Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix-Reference-Cited by-同舟云学术

Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix

Published:2017-01 Issue:1 Volume:144 Page:46-50
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Frumovitz M.^ORCID,Munsell M.F.,Burzawa J.K.,Byers L.A.,Ramalingam P.,Brown J.,Coleman R.L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference24 articles.

1. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients;Cohen;Am. J. Obstet. Gynecol.,2010

2. Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese gynecologic oncology group study;Wang;Eur. J. Cancer,2012

3. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence;Viswanathan;Gynecol. Oncol.,2004

4. Natural history and outcome of neuroendocrine carcinoma of the cervix;Margolis;Gynecol. Oncol.,2016

5. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document;Gardner;Gynecol. Oncol.,2011

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Cell Neuroendocrine Cervical Carcinoma: A Review;BioScientific Review;2024-07-13

2. Neuroendocrine cervical cancer: Have we made any steps forward in its management?;European Journal of Surgical Oncology;2024-07

3. State of the art of cervical cancer treatment in rare histologies;Frontiers in Oncology;2024-06-28

4. Innovations in Rare Gynecologic Cancer: Melanoma, Neuroendocrine, and Low-Grade Serous Ovarian;American Society of Clinical Oncology Educational Book;2024-06

5. Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead;Journal of Personalized Medicine;2024-04-27